Cannabis Cultivation and Extraction Potentially Costs 80% Less in Latin America

June 26, 2019

PALM BEACH, Florida, June 26, 2019 /PRNewswire/ — A recent article in the Green Fund said that: “The global cannabis market is thought to be worth USD$150 billion today (March 15, 2019). Barclays, in their European Consumer Staples Report in September...

Relevium’s Biocannabix Positions Itself as an Important Player in Colombia as it Pursues Endo-Medical Cannabis Strategy for Latin America

June 26, 2019

MONTREAL, June 26, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. a Health and Wellness portfolio company listed on TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX” (the “Company” or “Relevium”) announced today it is positioning itself as an important...

Relevium to Hold Investor Call to Discuss LATAM Strategy June 28, 2019 at 1:00pm EST

June 19, 2019

MONTREAL, June 19, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. a Health and Wellness portfolio company listed on TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX” (the “Company” or “Relevium”), is pleased to announce it will be holding a shareholder and...

Relevium’s Biocannabix Executes LOI to Acquire 30% Interest in Weedsense, a Late Stage Applicant for Standard Processing and Medical Sales License

June 5, 2019

MONTREAL, June 05, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce its wholly owned subsidiary Biocannabix Health Corporation (“Biocannabix”) has...

Relevium Provides Corporate Update on Its Medical Cannabis Strategy

June 3, 2019

MONTREAL, June 03, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide a corporate update on the Company’s positioning and strategy regarding medical cannabis...